May 6-9, 2025 | Estoril (Lisbon) Portugal
The Proveris team will welcome attendees at Exhibition Table 9 in the Nasal Spotlight Knowledge Space to learn about new innovative testing solutions for nasal drug product development. Ben Okorodudu, Vice President of Sales, and Grant Thurston, Product Manager at Proveris Scientific, will present a workshop on “The Emerging Role of Nasal Casts and Automation for the In Vitro Evaluation of Nasal Drug Products.”
Continuing our involvement with the Low GWP transition, we are collaborating with H&T Presspart on a scientific poster titled “Investigation of In Vitro Techniques for Evaluating Ipratropium Bromide Formulation.”
To learn more or schedule a meeting, please contact us at contactus@proveris.com
Respiratory Drug Delivery (RDD®) which is an international conference that brings together researchers, regulators, business professionals, and suppliers involved in pulmonary and nasal drug delivery. Over three days, attendees engage in expert lectures, a scientific poster hall, and an expansive exhibition will feature over 100 international companies, providing ample opportunities for networking and collaboration.
Learn more and register HERE.